Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

evolutionary science

dengue fever mosquito

Positive efficacy results for R21/Matrix-M malaria vaccine published in The Lancet

R21 was added to the World Health Organization's list of prequalified vaccines in December

- PMLiVE

Positive results for Astellas’ zolbetuximab in gastric cancer published in The Lancet

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

Positive results for Sanofi’s haemophilia therapy published in The Lancet

Fitusiran reduced annualised bleeding rates by 90% compared to control arms

- PMLiVE

Results for Astellas’ non-hormonal menopause drug published in The Lancet

Symptoms such as hot flashes and night sweats are the most common symptoms of menopause

- PMLiVE

Born strategic – Why great strategists are both born and made

You’ve probably met the sort of people I mean. You might even have had the good fortune to work with them and to learn from them. That person who seems...

- PMLiVE

UK report suggests last winter’s Omicron strain was less likely to cause ‘long COVID’

Data from nearly 100,000 people was gathered by a team from King’s College London

- PMLiVE

Nature’s way

There are business lessons to be learned from biological tragedies

- PMLiVE

Edging towards success

Evolution tells us to look for small advantages, not big leaps

- PMLiVE

Back to the future

Five years ago, an influential book used Darwin’s ideas to predict the future of the industry – how did that work out?

- PMLiVE

The Lancet confirms effectiveness of AZ/Oxford University’s COVID-19 vaccine

Final average efficacy analysis found to be 70.4%

The Midas Touch

Smart, but small, science can turn old ideas into gold

The secret of success

It is becoming clear that success in pharma is associated with specialisation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links